minoxidil has been researched along with Coronary Disease in 12 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of minoxidil on the electrocardiogram (EKG) were assessed in a prospective investigation of 112 patients with severe hypertension during an observation period representing 241." | 7.66 | Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil. ( Froer, KL; Hall, D; Rudolph, W, 1980) |
| "The effects of minoxidil on the electrocardiogram (EKG) were assessed in a prospective investigation of 112 patients with severe hypertension during an observation period representing 241." | 3.66 | Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil. ( Froer, KL; Hall, D; Rudolph, W, 1980) |
| "Eight patients with arteriosclerotic systolic hypertension whose blood pressure had been nonresponsive to conventional antihypertensive therapy, were given minoxidil in daily doses of 4 to 15 mg." | 3.66 | Hazards in treatment of systolic hypertension. ( Aygen, MM; Rosenfeld, JB; Traub, YM, 1979) |
| "Male pattern baldness, or androgenetic alopecia (AGA) in men, occurs with varying severity and age of onset." | 2.41 | Male pattern baldness. ( Chamberlain, M; Hogan, DJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, D | 1 |
| Froer, KL | 1 |
| Rudolph, W | 1 |
| Ram, CV | 2 |
| Mesfin, GM | 1 |
| Higgins, MJ | 1 |
| Robinson, FG | 1 |
| Zhong, WZ | 1 |
| Joseph, EC | 1 |
| Hogan, DJ | 1 |
| Chamberlain, M | 1 |
| Leenen, FH | 1 |
| Yuan, B | 1 |
| Ambrosio, GB | 1 |
| Pick, R | 1 |
| Glick, G | 1 |
| Traub, YM | 1 |
| Aygen, MM | 1 |
| Rosenfeld, JB | 1 |
| Dogterom, P | 1 |
| Zbinden, G | 1 |
| Reznik, GK | 1 |
| Langnickel, R | 1 |
| Bluth, R | 1 |
| Meese, RB | 1 |
5 reviews available for minoxidil and Coronary Disease
| Article | Year |
|---|---|
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1984 |
Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Coronary Disease; Cyclic Nucleotide Phosphodiesterases | 2000 |
Male pattern baldness.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Age of Onset; Alopecia; Coronary Disease; E | 2000 |
Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview.
Topics: Amines; Animals; Animals, Laboratory; Coronary Disease; Dogs; Humans; Minoxidil; Myocardium; Necrosi | 1992 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1985 |
7 other studies available for minoxidil and Coronary Disease
| Article | Year |
|---|---|
Serial electrocardiographic changes during long-term treatment of severe hypertension with minoxidil.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Child; Child, Preschool; Coron | 1980 |
Relationship between serum concentrations, hemodynamic effects, and cardiovascular lesions in dogs treated with minoxidil.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Drug Administrati | 1996 |
Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Pressure; Cardiomegaly; Coronary Disease; Coronary Ves | 2001 |
Minoxidil in resistant hypertension.
Topics: Coronary Disease; Humans; Hypertension; Minoxidil; Pyrimidines | 1977 |
Effects of propranolol, minoxidil, and clofibrate on cholesterol-induced atherosclerosis in stumptail macaques (Macaca arctoides).
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Clofibrate; Coronary Disease; Coronary Vessels; Diet, | 1977 |
Hazards in treatment of systolic hypertension.
Topics: Aged; Arteriosclerosis; Body Weight; Coronary Disease; Diuretics; Female; Follow-Up Studies; Humans; | 1979 |
[Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
Topics: Adrenergic alpha-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias | 1985 |